Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
The Opportunity Adobe Experience Manager (AEM) Assets is Adobes Digital Asset Management platform - an Analyst- and Market-ranked Leader in the category for over a decade, serving top Fortune 100 and 500 customers across segments. AEM Assets
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,
Company Description Revnuu is a marketing and commercialization partner for deep-tech and life sciences companies, helping transform complex innovations into category-leading brands. The team enables technical founders to focus on R&D while Revnuu manages the entire
Company Description Revnuu is a marketing and commercialization partner for deep-tech and life sciences companies, helping transform complex innovations into category-leading brands. The team enables technical founders to focus on R&D while Revnuu manages the entire
Select how often (in days) to receive an alert: Job Category: Marketing & Communications Requisition Id: 5632 Since 1967, Jet Aviation has been crafting flight in its smoothest form. From one hangar in Basel, Switzerland, to
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
About Unblu Unblu helps the worlds leading banks and insurance companies deliver conversational finance solutions. We provide highly secure engagement and collaboration software, enabling financial institutions to enrich the digital experience of their clients. By choosing